IRIS
MARRA, ANNAMARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 691
EU - Europa 495
AS - Asia 376
AF - Africa 2
Totale 1.564
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 688
CN - Cina 360
IE - Irlanda 190
FI - Finlandia 71
IT - Italia 65
UA - Ucraina 60
DE - Germania 49
FR - Francia 24
BE - Belgio 17
IN - India 11
GB - Regno Unito 10
SE - Svezia 6
CA - Canada 3
JP - Giappone 2
MU - Mauritius 2
BD - Bangladesh 1
GR - Grecia 1
KR - Corea 1
NL - Olanda 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 1.564
Salva come PNG Salva come JPEG
Città #
Dublin 190
Chandler 161
Jacksonville 95
Nanjing 94
Beijing 55
Ann Arbor 53
Ashburn 45
Nanchang 45
New York 38
Pavia 38
Princeton 33
Hebei 31
Lawrence 30
Changsha 28
Helsinki 28
Wilmington 25
Jiaxing 22
Tianjin 22
Shenyang 20
Piscataway 19
Medford 17
Brussels 13
Hangzhou 13
Shanghai 12
Seattle 11
Boardman 10
Milan 9
Pune 8
Couilly-pont-aux-dames 6
Los Angeles 6
Woodbridge 6
Fairfield 5
Guangzhou 5
Aachen 4
Dearborn 3
Tappahannock 3
Toronto 3
Jinan 2
Norwalk 2
Tokyo 2
Turin 2
Amsterdam 1
Borås 1
Dallas 1
Des Moines 1
Dhaka 1
Fuzhou 1
Gallarate 1
Jinhua 1
Ningbo 1
Novokuznetsk 1
Orange 1
Qingdao 1
Shaoxing 1
Temecula 1
West Palm Beach 1
Totale 1.229
Salva come PNG Salva come JPEG
Nome #
A step forward in understanding the binding of ELAV mimicking peptides to mRNA. An integrated computational and NMR approach 88
Studies on the Enantiomers of RC-33 as Neuroprotective Agents: Isolation, Configurational Assignment, and Preliminary Biological Profile 86
(R)-RC-33 as Promising Neuroprotective Agent Acting as Sigma1 Receptor Agonist 77
Sigma receptor modulators: a patent review. 75
Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists. 71
Identification of RC-33 as a potent and selective sigma1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability. 70
A step forward in the sigma enigma: a role for chirality in the sigma1 receptor- ligand interaction? 68
New biotinilated spacers for studying the interaction of ELAV mimicking peptides with the target mRNA 65
Towards sigma1 receptor agonists as neuroprotective agents. Preparation, configurational assignment and in vitro biological profile 63
Beyond the affinity for protein kinase C: Exploring 2-phenyl-3-hydroxypropyl pivalate analogues as C1 domain-targeting ligands 61
A step forward in the sigma enigma: the role of chirality in the interaction ligand-sigma1 receptor 58
Development of easy-to-use reverse-phase liquid chromatographic methods for determining PRE-084, RC-33 and RC-34 in biological matrices. The first step for in vivo analysis of sigma1 receptor agonists. 54
PAN-SIGMA RECEPTOR MODULATORS AS PROMISING ANTICANCER-AGENTS. THE STORY OF RC-106 53
Beyond the affinity for the Protein Kinase C: a critical evaluation of 2-fenil-3hydroxypropyl pivalate analogs targeting the C1 domain 51
Enantiomeric 4-Acylamino-6-alkyloxy-2 Alkylthiopyrimidines As Potential A3 Adenosine Receptor Antagonists: HPLC Chiral Resolution and Absolute Configuration Assignment by a Full Set of Chiroptical Spectroscopy 51
“Fit-for-purpose” development of analytical and (semi)preparative enantioselective high performance liquid and supercritical fluid chromatography for the access to a novel sigma1 receptor agonist. 50
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 50
Use of arylalkanolamines as sigma-1 receptor antagonists 49
Studies on the enantiomers of RC-33, promising neuroprotective agents acting as sigma1 receptor agonists. Isolation, configurational assignment and biological profile 48
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents 47
In vivo pharmacokinetic study and CNS distribution of the sigma1 receptor agonist (R)-RC-33, a promising neuroprotective agent 47
Sigma Receptors: Novel Targets For The Treatment Of Highly Malignant Tumors 46
Synthesis and in vitro evaluation of novel pan-SR modulators: Identification of (E)-4-benzyl-1-[3-(naphthalen-2-yl)but-2-en-1-yl]piperidine (RC-106) as potential anticancer agent. 45
On the study of stereoselectivity in the ligand - Sigma1 receptor interaction. 44
Chemical, pharmacological and in vivo pharmacokinetic studies on enantiomerically pure RC-33 compounds, promising neuroprotective agents acting as sigma1 receptor agonists 43
Novel enantiopure sigma receptor modulators: Quick (semi-)preparative chiral resolution via hplc and absolute configuration assignment 42
Sigma1 Receptor Agonists in motor dysfunction pathologies treatment – a medicinal chemistry perspective 40
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 36
Towards the identification of neuroprotective agents. Pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising sigma1 receptor agonist 30
Towards sigma1 receptor agonists as neuroprotective agents. Chemical and pharmacological studies of RC-33 enantiomers 23
Sigma receptor and aquaporin modulators: chiral resolution, configurational assignment, and preliminary biological profile of RC752 enantiomers 2
Totale 1.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.288
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.288
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 2 1
2019/2020419 119 170 4 11 5 13 1 19 20 25 30 2
2020/2021149 13 14 2 16 2 22 0 30 12 22 13 3
2021/2022160 1 2 4 2 3 3 2 9 14 3 17 100
2022/2023498 56 48 4 29 41 48 0 27 218 5 10 12
2023/2024214 30 27 1 4 19 75 13 16 2 8 19 0
Totale 1.633